The Effect of Virtual Reality on Patient Outcome

NANot yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

November 1, 2025

Conditions
Virtual RealityCoronary Angiography (CAG)
Interventions
OTHER

İntervention

Patients participating in the study will be informed about the purpose of the study. Participants will be included in the study after verbally and in writing confirming the informed consent form. Patients will receive training and information about the virtual reality headset before the procedure. Patients will complete a personal information form 1 hour before the coronary angiography procedure. Pain and anxiety levels will be measured using the Visual Analog Scale (VAS) and the State Anxiety Scale 10 minutes before the procedure. Patients in the intervention group will wear virtual reality headsets during coronary angiography. Local anesthesia will not be administered to the femoral intervention site in these patients. Pain and anxiety will be assessed after the coronary angiography procedure (10 minutes later). Patients will also be questioned about their satisfaction with the virtual reality application after the procedure. One week after discharge, the patient will be re-evaluate

OTHER

Control

Ten minutes before the coronary angiography procedure, patients will be assessed for pain and anxiety using the Visual Analog Scale (VAS) and the State Anxiety Scale. During the coronary angiography, control group patients will undergo routine interventional procedures. Following the coronary angiography procedure (10 minutes later), patients will be assessed for pain and anxiety. One week after discharge, the patient will be re-evaluated at the hospital for an interventional site examination. The femoral area will be examined for edema, hematoma, pain, and difficulty walking. These assessments will be recorded on forms.

All Listed Sponsors
lead

HARUN ÜNAL

OTHER

NCT07138430 - The Effect of Virtual Reality on Patient Outcome | Biotech Hunter | Biotech Hunter